Development and validation of support tools for advance care planning in patients with chronic heart failure
Yasuko Takada(National Cerebral and Cardiovascular Center), Yoshihiro Fukumoto(Kurume University), Mitsunori Nishikawa(National Center for Geriatrics and Gerontology), Hisao Ogawa(Kumamoto University Hospital), Yasuhiro Hamatani(National Cerebral and Cardiovascular Center), Masashi Kato, Toshihisa Anzai(Hokkaido University), Michikazu Nakai(National Cerebral and Cardiovascular Center), Yuta Anchi(National Cerebral and Cardiovascular Center), Hiroto Ito(National Center of Neurology and Psychiatry), Tsuyoshi Shiga(Tokyo Women's Medical University), Chisato Izumi(National Cerebral and Cardiovascular Center), Satoshi Yasuda(Tohoku University), Atsushi Suzuki(Tokyo Women's Medical University), Yasuo Sugano(keiyu Hospital), Yukie Kawano(National Cerebral and Cardiovascular Center), Tatsuhiro Shibata(United Cerebral Palsy)
Cited by 10
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755